STAA Staar Surgical Co
Updated
Staar Surgical Co (STAA) is a healthcare company in the Ophthalmic Goods industry, with a market capitalization of $1.2 billion. Shares last traded at $23.57, 34.5% below their 52-week high. Over the past year the stock is down 13.7%. STAA trades at a price-to-earnings ratio of 307.86, above the Ophthalmic Goods median of 167.20. Net profit margin is 1.1%, in line with the peer median of 1.1%. Revenue declined 23.7% year over year.
Performance
Chart
Full chart →Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.
Technicals
Financials
Latest reported annual period ending 2026-07-03 · SEC EDGAR/XBRL.
Recent earnings
| Period | EPS (diluted) | Reported |
|---|---|---|
| Q2 2026 | $0.26 | 2026-08-12 |
| Q1 2026 | $0.10 | 2026-05-13 |
| FY 2025 | $-1.62 | 2026-03-03 |
| Q3 2025 | $-1.26 | 2025-11-05 |
| Q2 2026 | $-1.44 | 2026-08-12 |
| Q1 2026 | $-1.10 | 2026-05-13 |
Ophthalmic Goods peers
STAA vs 9 industry peers (Ophthalmic Goods), by market cap. Updated
| COO | Cooper Companies (The) | $13.4B | 23.55 | 3.17 | 13.5% | +1.31% |
| BLCO | Bausch & Lomb Corp | $6.5B | -37.89 | 1.22 | -3.2% | +0.72% |
| WRBY | Warby Parker Inc. | $2.9B | 372.01 | 3.16 | 0.8% | -2.65% |
| EYE | National Vision Holdings, Inc. | $1.3B | 26.53 | 0.66 | 2.5% | +0.42% |
| STAA | Staar Surgical Co | $1.2B | 307.86 | 3.48 | 1.1% | +1.90% |
| RXST | Rxsight, Inc. | $272M | -5.79 | 2.24 | -38.8% | -7.24% |
| LUCY | Innovative Eyewear Inc | $8M | -1.02 | — | — | -2.08% |
| ALC | Alcon Inc | — | — | — | 30.8% | -0.21% |
| LUCYW | Innovative Eyewear Inc | — | — | — | — | -2.96% |
Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.